PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

PAR is far better than you know!

  1. jtl
    81 Posts.
    lightbulb Created with Sketch. 34
    I thought I would give another inside into my story, having been under the SAS program from early last year. It worked well with no side affects, it changed my life.
    If you have severe OA like mine, it is a terrible pain that I can not explain and you will do anything to relive the pain. I used heavy pain killers and anti inflammatories to alleviate pain, however this is only a short term fix and comes with terrible drowsiness and other health problems. The amount of pain killers I would need, would turn me into a walking zombie. The anti inflammatories did not work, and I tried a few different ones.
    I am a true believer of PPS and hope PAR have all the success to bring this drug into commercialisation. I have invested in PAR, not just from an monetary point of view but from a user that needs this company to succeed. I want to keep my knee!!
    Back in March of this year I was able to get another dose or booster if you want to call it. They did not have enough of PPS at the time, I was told due to them obtaining new vials (FDA requirement) for the US market and also to accommodate the phase 3 trials in the US, plus increased demand with SAS program Australia wide.
    PAR is not going to order a absurd amount of PPS until they have a guarantee of a consistent supply chain with the appropriate authorities backing IMO.
    I was given only four doses and can tell you, I feel great and just as good as my 12 doses from last year. I was injected in the backside instead of the stomach as last years doses did leave red marks on the stomach and were slightly itchy. It worked well and no marks or itchiness on my backside (very top part of the buttocks, almost lower back, if you want to know) IMO the drug is far better than expected and I believe it will grab a wider market if this is the case. Sure you investors will lose on the $$ per dose, however it will also attract a larger market due to cost savings IMO.
    Not only that I feel we will be able to inject in different sites that suit the user and still have the same affects IMO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.95M
Open High Low Value Volume
24.5¢ 25.5¢ 24.0¢ $258.1K 1.049M

Buyers (Bids)

No. Vol. Price($)
4 135166 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 101490 2
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.